Macedo, J.M.Baylina, PilarFernandes, R.2023-02-142023-02-142019-04Macedo, J. M., Baylina, P., & Fernandes, R. (2019). Diabetes risk assessment: Clinical screening tools. Workshop on R&D Projects: Proceedings, 24–26.http://hdl.handle.net/10400.22/22281The epidemic of type 2 diabetes (T2D) continues to soar worldwide. Driven by changes in human habits, from availability of energy dense processed foods to the decrease of physical activity, T2D constitutes already a heavy burden of disease and a worrisome barrier for the sustainability of National Health Systems. Indeed, it affects 415 million people (8.8% prevalence), was responsible for 5.0 million deaths in 2015, and is estimated to cost 1/9 of all Health expenses. Within Europe, Portugal is reported as having the highest prevalence of diabetes: an estimated 9.6% by World Standard Population. But if we take into consideration the age distribution of the Portuguese population, then estimates increase to 12.9%. This means that 1 million Portuguese have diabetes, with almost half of these still undiagnosed. Additionally, 2 million (a third of the adult population) are estimated to have intermediate hyperglycemia (or prediabetes), being largely unaware of this condition.engType 2 diabetes mellitusPrediabetesDiabetes risk assessmentDiabetes risk scoreconference object